The broad objective of the proposed project is to clarify the molecular pathology of bronchoconstriction, hyperreactivity, and mucous hypersecretion. The investigations proposed here possess implications of potential importance for the comprehension and management of airway diseases ranging from cystic fibrosis to asthma and anaphylaxis. The focus will be the participation of mast cell-derived extracellular proteases and their inhibitors in the initiation and maintenance of pathologic airway states. The abundant granule-associated proteases of several lines of canine mastocytoma cells propogated in athymic mice will be isolated and examined in biochemical detail. Characterization will include the ability to activate or inactivate vasoactive and neuroendocrine peptides found in the lung. Sensitive chromogenic substrates will be developed and tested for their ability to detect active proteases released into secretions of the intact airway or the medium of cultured airway cells, with diverse immunologic and nonimmunologic stimuli. Immunohistochemical reagents prepared from antibodies to purified proteases and inhibitors will be employed to localize these proteins in canine airways and to define functional and molecular bases for mast cell heterogeneity. Effects of purified proteins on epithelial cell functions, gland secretion, and bronchomotor tone will be examined in cultured airway cells, tracheal explants, and allergic dogs. This approach is intended to establish the chemical credibility of actions identified with airway proteases and their inhibitors, in tandem with their physiologic significance. These investigations may suggest specific therapeutic approaches to airway diseases triggered or sustained by protease/inhibitor imbalance or the pathologic release of proteases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08HL001736-02
Application #
3082111
Study Section
(SRC)
Project Start
1986-05-01
Project End
1991-04-30
Budget Start
1987-05-01
Budget End
1988-04-30
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Soto, D; Malmsten, C; Blount, J L et al. (2002) Genetic deficiency of human mast cell alpha-tryptase. Clin Exp Allergy 32:1000-6
Caughey, G H; Zerweck, E H; Vanderslice, P (1991) Structure, chromosomal assignment, and deduced amino acid sequence of a human gene for mast cell chymase. J Biol Chem 266:12956-63
Caughey, G H (1991) The structure and airway biology of mast cell proteinases. Am J Respir Cell Mol Biol 4:387-94
Caughey, G H; Raymond, W W; Vanderslice, P (1990) Dog mast cell chymase: molecular cloning and characterization. Biochemistry 29:5166-71
Rubinstein, I; Nadel, J A; Graf, P D et al. (1990) Mast cell chymase potentiates histamine-induced wheal formation in the skin of ragweed-allergic dogs. J Clin Invest 86:555-9
Vanderslice, P; Ballinger, S M; Tam, E K et al. (1990) Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc Natl Acad Sci U S A 87:3811-5
Tam, E K; Caughey, G H (1990) Degradation of airway neuropeptides by human lung tryptase. Am J Respir Cell Mol Biol 3:27-32
Tam, E K; Franconi, G M; Nadel, J A et al. (1990) Protease inhibitors potentiate smooth muscle relaxation induced by vasoactive intestinal peptide in isolated human bronchi. Am J Respir Cell Mol Biol 2:449-52
Vanderslice, P; Craik, C S; Nadel, J A et al. (1989) Molecular cloning of dog mast cell tryptase and a related protease: structural evidence of a unique mode of serine protease activation. Biochemistry 28:4148-55
Pison, U; Tam, E K; Caughey, G H et al. (1989) Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastase. Biochim Biophys Acta 992:251-7

Showing the most recent 10 out of 21 publications